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Abstract To prospectively evaluate the associations of
dietary calcium and magnesium intake with cancer inci-
dence and mortality, data of 24,323 participants of the
Heidelberg cohort of the European Prospective Investiga-
tion into Cancer and Nutrition (EPIC-Heidelberg), who
were aged 35–64 years and cancer-free at recruitment
(1994–1998), were analyzed using multivariate Cox
regression models. After an average follow-up time of
11 years, 2,050 incident cancers were diagnosed and 513
cancer deaths occurred. Dietary calcium intake was
inversely but not statistically significantly associated with
colorectal cancer risk (hazard ratio [HR] for per 100 mg
increase in intake: 0.95; 95% confidence interval [CI]:
0.88, 1.02) and lung cancer risk (HR for per 100 mg
increase in intake: 0.94; 95% CI: 0.87, 1.02). No statisti-
cally significant associations were observed between die-
tary calcium intake and site-specific or overall cancer
incidence or mortality. Dietary magnesium intake was not
statistically significantly associated with any of the inves-
tigated outcomes. This prospective cohort study provides
no strong evidence to support that high dietary calcium and
magnesium intake in the intake range observed in a German
population may reduce cancer incidence or mortality.
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Introduction
Besides its importance in maintaining bone health, calcium
is also a key nutrient involved in processes of cell prolif-
eration and carcinogenesis [1, 2]. Many epidemiological
studies have evaluated the association between dietary
calcium intake and risks of various cancer types. A grow-
ing body of evidence suggests a protective effect of high
dietary calcium intake on colorectal cancer [3–8] and
breast cancer risk [9–14]. Meanwhile, a number of studies
have also suggested that high calcium intake might
increase the risk of prostate cancer [15–21].
Magnesium is another important mineral with various
metabolic and physiological functions that may influence
carcinogenesis [22–24]. Although animal studies have con-
sistently suggested an inhibitory effect of dietary magnesium
intake on colorectal cancer risk [25–29], available epide-
miological findings are few and far from being conclusive
[30–33]. Relationships between dietary magnesium intake
and the risks of other common site-specific cancers have
been scarcely reported in literatures.
So far, only one study has reported the associations
between dietary calcium and magnesium intake and cancer
mortality [34]. In that study, neither dietary calcium intake
nor magnesium intake was associated with overall cancer
mortality.
We hereby report the associations of dietary calcium
and magnesium intake with cancer incidence and cancer
mortality in a German prospective cohort.
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Methods
Study population
Heidelberg is one of the two German areas that joined
the European Prospective Investigation into Cancer and
Nutrition (EPIC) study. In 1994–1998, 11,928 men (aged
40–64 years) and 13,612 women (aged 35–64 years) were
recruited into the EPIC-Heidelberg cohort. The recruitment
procedures have been described elsewhere [35]. The study
protocol was approved by the Ethics Committee of the
Heidelberg University Medical School. All participants
provided informed consent. In the present study, we excluded
participants whose total daily energy intake was in the top or
bottom 0.5 sex-specific percentile (men:\887/[5,582 kcal/
day; women:\703/[4,381 kcal/day; n = 257) and partici-
pants with a diagnosis of cancer at recruitment stage
(n = 953), leaving 24,323 participants for analysis.
Assessment of dietary calcium and magnesium intake
and other exposures
Diet in the last 12 months before recruitment was assessed
using a self-administered food frequency questionnaire
(FFQ) that had been validated by 12 24-h diet recalls [36,
37]. Dietary intakes of nutrients were derived using the
German Dietary Nutrient Database BSL, version II.3. For
the entire EPIC-Germany cohort, the main dietary sources
of calcium were milk/milk products (39.9% for men and
38.7% for women) and non-alcoholic beverages (28.2% for
men and 34.4% for women); the main dietary sources of
magnesium were non-alcoholic beverages (25.1% for men
and 33.7% for women) and cereals (22.6% for men and
20.6% for women) [38]. At food group level, the Spearman
correlation coefficient between the mean of 12 24-h diet
recalls and FFQ was 0.58 for milk/milk products and
cheese, 0.70 for non-alcoholic beverages, and 0.55 for
cereals [36]. Regular use of dietary supplements in the last
4 weeks before recruitment was assessed. However, dosage
data were not collected. Baseline demographic, lifestyle,
and other health-related data were collected in a face-to-
face interview and by questionnaires.
Ascertainment of disease outcomes
Incident diseases and deaths that occurred during follow-up
were reported by study participants or their next of kin in
regular follow-up questionnaire surveys. Reported incident
diseases were verified by reviewing medical records from
hospitals. For deceased participants, the underlying cause
of death was obtained from the official death certificate.
In the present study, disease outcomes of interest, along
with the corresponding codes in the International Classifi-
cation of Disease (10th Revision, ICD-10), included:
incident colorectal cancer (C18-C20), incident lung cancer
(C34), incident prostate cancer (C61), incident breast
cancer (C50), and overall cancer incidence and mortality
(B21 and C00-C97).
Statistical analyses
The residual method [39] was used to adjust dietary
nutrient intakes for total energy intake. We categorized
energy-adjusted dietary calcium and magnesium intake
into quartiles using sex-specific cut-off points. To compare
age-adjusted baseline characteristics across quartiles, we
performed analysis of covariance and logistic regression
[40]. Multivariate Cox regression models were fitted to
estimate hazard ratios (HRs) and 95% confidence intervals
(CIs) for both quartiles and per 100 mg increase in dietary
calcium and magnesium intake. For the former, likelihood
ratio tests were performed to test the statistical significance
of linear trend, with medians of quartiles modeled as a
continuous variable. For the latter, energy-adjusted calcium
and magnesium intake were divided by 100 so that one unit
represented an actual intake of 100 mg. Multivariate
models adjusted for the following covariates: sex, age at
recruitment (years), educational level (none/primary,
technical/secondary, and university), physical activity
(inactive, moderately inactive, moderately active, and
active [41]), body mass index (BMI, kg/m2), waist-to-hip
ratio, smoking categories (never smoker; former smoker,
quit C10 years, quit \10 years; and current smoker,
B10, 11–20, [ 20 cigarettes/day), lifetime alcohol intake
(g/day), dietary fiber intake (g/day), meat/meat product
intake (g/day), and total energy intake (kcal/day). All these
covariates, with exception of sex and calcium/vitamin D
supplementation, altered the exposure-disease effect for
5% or greater. For the analysis of dietary calcium intake,
dietary vitamin D and K2 intake (lg/day) and regular use of
calcium/vitamin D supplements (yes/no) were additionally
adjusted for. The reason for adjusting for dietary vitamin
K2 intake is that vitamin K2 intake, which closely corre-
lates with dietary calcium intake (r = 0.63), was signifi-
cantly inversely associated with lung and prostate cancer
incidence and overall cancer mortality in our cohort [42].
For overall cancer incidence and mortality, we further
performed a sex-specific analysis and 2-year lag analysis
by excluding cancer cases or deaths that occurred in the
first 2 years of follow-up. Two-sided p \ 0.05 was con-
sidered statistically significant. SAS software (version 9.2;
SAS Institute, Cary, NC) was used to perform all statistical
analyses.
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Results
Age-adjusted baseline characteristics of participants are
shown in Table 1. Participants with higher dietary calcium
and magnesium intake were more likely to have a university
degree, to be physically active, and to regularly take cal-
cium/vitamin D supplements. Participants with higher die-
tary calcium intake also had a shorter smoking duration and
a lower lifetime alcohol intake. Higher dietary calcium and
magnesium intake were associated with certain favorable
dietary factors, such as higher dietary intakes of vitamin D
and fiber, but a lower intake of meat/meat products.
During an average follow-up time of 11 years, 2,050
incident cancer cases were diagnosed and 513 cancer deaths
occurred. Dietary calcium intake in quartiles was not sta-
tistically significantly associated with overall or common
site-specific (colorectum, lung, prostate, and breast) cancer
incidence and overall cancer mortality (Table 2). We also
ran models without adjusting for vitamin K2 intake,
resulting in a statistically significantly inverse association
of dietary calcium intake with lung cancer risk (HR for
highest vs. lowest quartile: 0.61; 95% CI: 0.38, 0.98;
ptrend = 0.02), a non-significantly inverse association with
prostate cancer risk (HR for highest vs. lowest quartile:
0.77; 95% CI: 0.56, 1.05; ptrend = 0.07), and a non-signif-
icantly inverse association with overall cancer mortality
(HR for highest vs. lowest quartile: 0.79; 95% CI: 0.61,
1.02; ptrend = 0.07). When treated as a continuous variable,
per 100 mg increase in dietary calcium intake was inversely
yet not statistically significantly associated with colorectal
cancer risk (HR: 0.95; 95% CI: 0.88, 1.02) and lung cancer
risk (HR: 0.94; 95% CI: 0.87, 1.02).
As shown in Table 3, dietary magnesium intake, either
in quartiles or as a continuous variable, was not statistically
significantly associated with overall cancer incidence and
mortality. For site-specific cancer incidence, per 100 mg
increase in dietary magnesium intake was inversely but not
statistically significantly associated with lung cancer risk
(HR: 0.75; 95% CI: 0.51, 1.11).
The sex-specific analysis and exclusion of cases diag-
nosed within the first 2 years after recruitment did not
produce substantially different results (data not shown).
Table 1 Age-adjusted baseline characteristics of the EPIC-Heidelberg participants by sex-specific quartiles of dietary calcium and magnesium
intake, 1994–1998
Quartiles of dietary calcium intake Quartiles of dietary magnesium intake
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
No. of participants (n) 6,070 6,095 6,072 6,086 6,143 6,039 6,048 6,093
Men (%) 47.0 47.0 46.8 47.0 46.9 47.8 46.7 46.4
Age at recruitment (years) 51.3 50.7 50.4 50.7 50.1 50.7 51.0 51.2
University degree (%) 21.2 28.6 33.0 37.6 22.2 29.9 32.6 35.8
Physically active (%) 22.4 24.0 24.2 28.8 22.0 23.2 24.7 29.5
BMI (kg/m2) 26.2 26.2 26.1 26.0 26.3 26.2 26.2 25.8
Waist-to-hip ratio 0.87 0.87 0.87 0.86 0.87 0.87 0.87 0.86
Smoking duration (years) 13.6 12.0 11.8 11.8 12.4 12.0 12.3 12.5
Lifetime alcohol intake (g/day) 21.7 17.8 15.6 13.9 15.4 16.9 17.9 18.6
Dietary calcium intake (mg/day)a 512 675 820 1,131 655 745 808 930
Dietary magnesium intake (mg/day)a 293 308 322 345 261 299 328 381
Dietary vitamin D intake (lg/day)a 3.0 3.3 3.3 3.4 3.2 3.2 3.3 3.3
Dietary vitamin K2 intake (lg/day)
a 28.0 33.5 37.9 44.3 36.6 37.0 35.8 34.2
Dietary fiber (g/day)a 18.4 19.9 20.5 21.0 16.6 18.7 20.6 24.0
Meat/meat product intake (g/day) 119.7 103.8 92.1 76.4 110.2 106.3 96.5 77.8
Total energy intake (kcal/day) 1,974 1,971 1,929 1,954 1,960 1,957 1,961 1,950
Regular use of Ca/vitamin D supplementsb (%) 7.5 8.3 9.6 11.5 7.4 8.4 9.4 11.4
Participants with a diagnosis of cancer at recruitment and participants whose total daily energy intake was in the top or bottom 0.5 sex-specific
percentile (men: \887/[5,582 kcal/day; women: \703/[4,381 kcal/day) were excluded
BMI body mass index, EPIC European Prospective Investigation into Cancer and Nutrition
 ptrend \ 0.05, tested by using Cochran-Armitage method for categorical variables and generalized linear model for continuous variables.
Values are means or percentages
a Adjusted for total energy intake using the residual method
b Including multivitamins/minerals
Cancer Causes Control (2011) 22:1375–1382 1377
123
Discussion
After an average follow-up time of 11 years of the EPIC-
Heidelberg cohort, we observed statistically non-signifi-
cantly inverse associations of dietary calcium intake with
colorectal and lung cancer risk. There were no statistically
significant associations between dietary magnesium intake
and cancer incidence and mortality.
Dietary calcium intake
In the present study, dietary calcium intake was not asso-
ciated with overall cancer incidence, in contrast to a pre-
vious study showing a significantly inverse association in
women but not in men [43]. In our cohort, the null asso-
ciation between dietary calcium intake and overall cancer
incidence was not modified by sex. Two meta-analyses of
observational and interventional studies consistently sug-
gest that high dietary calcium intake may reduce colorectal
cancer risk [3, 44]. A possible mechanism for this protec-
tive effect is that free calcium in colon can bind bile acids
and fatty acids and consequently prohibit the proliferation
and differentiation of colorectal epithelial cell [45–49].
In the present study, we observed no significantly inverse
association between the energy-adjusted dietary calcium
intake and colorectal cancer risk. However, the absolute
dietary calcium intake was significantly inversely associ-
ated with colorectal cancer risk according to the standard
model that controlled for total energy intake as a con-
founder (HR for highest vs. lowest quartile: 0.46; 95% CI:
0.26, 0.79; ptrend = 0.01).
The relationship between dietary calcium intake and
lung cancer risk has been rarely reported. Our finding of the
non-significantly inverse association is not in agreement
Table 2 Multivariate HRs and 95% CIs for cancer incidence and mortality by quartiles of dietary calcium intake in the EPIC-Heidelberg cohort,
1994–2010
Quartiles of dietary calcium intake Intake as
continuous variablea
Q1 Q2 Q3 Q4 ptrend
Overall cancer incidence
No. of cases 555 511 489 495
HR (95% CI) 1.00 (ref) 1.01 (0.89–1.15) 1.01 (0.89–1.16) 1.04 (0.90–1.20) 0.75 1.01 (0.99–1.03)
Colorectal cancer
No. of cases 59 55 47 40
HR (95% CI) 1.00 (ref) 1.03 (0.71–1.52) 0.93 (0.61–1.42) 0.80 (0.50–1.30) 0.32 0.95 (0.88–1.02)
Lung cancer
No. of cases 67 28 25 27
HR (95% CI) 1.00 (ref) 0.66 (0.41–1.05) 0.64 (0.38–1.07) 0.71 (0.41–1.21) 0.50 0.94 (0.87–1.02)
Prostate cancer
No. of men 2,854 2,866 2,840 2,861
Mean intake (mg/day) 510 678 830 1,163
No. of cases 102 103 98 84
HR (95% CI) 1.00 (ref) 1.07 (0.80–1.42) 1.04 (0.77–1.41) 0.83 (0.58–1.18) 0.23 0.99 (0.94–1.03)
Breast cancer
No. of women 3,216 3,229 3,232 3,225
Mean intake (mg/day) 515 673 812 1,102
No. of cases 102 99 106 108
HR (95% CI) 1.00 (ref) 0.95 (0.72–1.27) 0.98 (0.73–1.31) 0.98 (0.71–1.35) 0.93 1.02 (0.97–1.06)
Overall cancer mortality
No. of cases 173 118 113 109
HR (95% CI) 1.00 (ref) 0.85 (0.66–1.08) 0.88 (0.68–1.15) 0.90 (0.68–1.20) 0.52 0.98 (0.95–1.03)
Adjusted for sex, age at recruitment, educational level, physical activity, BMI, waist-to-hip ratio, smoking category, lifetime alcohol intake,
meat/meat product intake, dietary intakes of vitamin D, vitamin K2, and fiber, total energy intake, and regular use of Ca/vitamin D supplements.
For lung cancer incidence, dietary magnesium intake was additionally adjusted for
Participants with a diagnosis of cancer at recruitment and participants whose total daily energy intake was in the top or bottom 0.5 sex-specific
percentile (men: \887/[5,582 kcal/day; women: \703/[4,381 kcal/day) were excluded
BMI body mass index, CI confidence interval, EPIC European Prospective Investigation into Cancer and Nutrition, HR hazard ratio
a For per 100 mg increase in dietary calcium intake
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with the results of two previous observational studies,
which showed either a significant positive association or a
null association [43, 50]. However, in the model that
ignored dietary vitamin K2 intake, the association became
statistically significant, suggesting a confounding effect of
dietary vitamin K2.
We observed no statistically significant association
between dietary calcium intake and prostate cancer risk,
consistent with the result of a meta-analysis of 45 obser-
vational studies [51], but not in line with the significant
positive association reported in another meta-analysis of 10
prospective cohort studies, in which the median dietary
calcium intake of the highest category ranged from 1,329
to 2,250 mg/day [21]. In the EPIC-Heidelberg cohort, the
median dietary calcium intake of the highest quartile was
1,132 mg/day. We may assume that only a very high die-
tary calcium intake can increase prostate cancer risk.
However, a cohort study of Chinese men has suggested that
dietary calcium intake may increase prostate cancer risk
even at a substantially low intake [52], implying that the
real dose–response relationship could be complicated. On
the other hand, the primary source of calcium in western
diets is milk and milk products. Besides calcium, some
other dairy components, such as saturated fat, dairy protein,
and hormones, are also risk factors for prostate cancer [15,
53, 54] and therefore may confound the association
between dietary calcium intake and prostate cancer risk. In
the present study, however, adjustment for milk/milk
product intake did not substantially change the association
between dietary calcium intake and prostate cancer risk.
Meanwhile, milk/milk product intake itself was not statis-
tically significantly associated with prostate cancer risk
either. Some studies have suggested that high dietary cal-
cium intake might have a more pronounced adverse effect
Table 3 Multivariate HRs and 95% CIs for cancer incidence and mortality by quartiles of dietary magnesium intake in the EPIC-Heidelberg
cohort, 1994–2010
Quartiles of dietary magnesium intake Intake as
continuous variablea
Q1 Q2 Q3 Q4 ptrend
Overall cancer incidence
No. of cases 513 505 463 569
HR (95% CI) 1.00 (ref) 0.99 (0.88–1.13) 0.90 (0.79–1.03) 1.12 (0.97–1.29) 0.19 1.06 (0.95–1.18)
Colorectal cancer
No. of cases 48 54 51 48
HR (95% CI) 1.00 (ref) 1.18 (0.79–1.76) 1.18 (0.76–1.81) 1.27 (0.76–2.10) 0.41 1.14 (0.78–1.68)
Lung cancer
No. of cases 47 34 34 32
HR (95% CI) 1.00 (ref) 0.80 (0.51–1.26) 0.88 (0.55–1.42) 0.83 (0.49–1.43) 0.52 0.75 (0.51–1.11)
Prostate cancer
No. of men 2,883 2,887 2,824 2,827
Mean intake (mg/day) 287 330 362 421
No. of cases 88 108 84 107
HR (95% CI) 1.00 (ref) 1.19 (0.89–1.58) 0.91 (0.66–1.25) 1.07 (0.76–1.49) 0.96 0.96 (0.76–1.21)
Breast cancer
No. of women 3,260 3,152 3,224 3,266
Mean intake (mg/day) 235 271 298 347
No. of cases 113 101 90 111
HR (95% CI) 1.00 (ref) 0.93 (0.70–1.22) 0.77 (0.57–1.04) 0.97 (0.69–1.35) 0.68 0.90 (0.67–1.20)
Overall cancer mortality
No. of cases 139 109 127 138
HR (95% CI) 1.00 (ref) 0.80 (0.62–1.03) 0.95 (0.74–1.23) 1.04 (0.79–1.36) 0.62 1.04 (0.85–1.28)
Adjusted for sex, age at recruitment, educational level, physical activity, BMI, waist-to-hip ratio, smoking category, lifetime alcohol intake,
meat/meat product intake, dietary intake of fiber, and total energy intake. For colorectal, lung, and prostate cancer incidence and overall cancer
mortality, dietary calcium and vitamin K2 intake were additionally adjusted for
Participants with a diagnosis of cancer at recruitment and participants whose total daily energy intake was in the top or bottom 0.5 sex-specific
percentile (men: \887/[5,582 kcal/day; women: \703/[4,381 kcal/day) were excluded
BMI body mass index, CI confidence interval, EPIC European Prospective Investigation into Cancer and Nutrition, HR hazard ratio
a For per 100 mg increase in dietary magnesium intake
Cancer Causes Control (2011) 22:1375–1382 1379
123
on advanced/fatal prostate cancer risk [20, 55, 56]. How-
ever, the present study observed no such a result (data not
shown). Again, the present study reveals a confounding
effect of dietary vitamin K2 on the association between
dietary calcium intake and prostate cancer risk, as sug-
gested by the strengthened inverse association in the
vitamin K2-unadjusted model.
We observed no significantly inverse association
between dietary calcium intake and breast cancer risk as
reported in previous studies [9–14]. Some of these studies
showed that the inverse association was particularly strong
for premenopausal women [10, 11, 13, 14]. In the present
study, however, menopausal status did not modify the null
association (data not shown).
In the present study, the vitamin K2-unadjusted model
produced an inverse association between dietary calcium
intake and overall cancer mortality, not supporting the null
association reported in one prospective study of Swedish
men [34]. In our cohort, dietary vitamin K2 intake was
significantly inversely associated with overall cancer
morality (HR for highest vs. lowest quartile: 0.72; 95% CI:
0.53, 0.85; ptrend = 0.03) [42]. The substantially attenuated
inverse association due to the adjustment for dietary vita-
min K2 intake suggests that dietary calcium intake may
have no independent effect on overall cancer mortality. It is
also notable that the mean energy-adjusted dietary calcium
intake in the Swedish male cohort was much higher than
that in our cohort (1,400 vs. 784 mg/day for the entire
cohort and 795 mg/day for the sub-cohort of men). In such
a population that is less likely to have suboptimal calcium
supply, an independent effect of dietary calcium intake,
assuming it really exists, may be more difficult to detect.
Dietary magnesium intake
To the best of our knowledge, the association between
dietary magnesium intake and overall cancer incidence has
never been reported before, and thus, the null association
that we observed here needs to be confirmed or refuted by
others. For site-specific cancer incidence, our result sup-
ports the finding of a Dutch cohort study that dietary
magnesium intake was not associated with colorectal can-
cer risk [33]. Three other prospective cohort studies of
women reported either a significantly inverse association or
a null association [30–32]. The average energy-adjusted
dietary magnesium intakes in these cohorts were 289, 232,
and 329 mg/day, respectively, comparable to that of our
female sub-cohort (288 mg/day). However, the small
number of incident colorectal cancer cases in our cohort
does not permit a meaningful separate analysis for women.
So far, only very few epidemiological studies have
evaluated the association between dietary magnesium
intake and lung, prostate, and breast cancer risk. In one
case–control study, dietary magnesium intake was signifi-
cantly inversely associated with lung cancer risk [57]. In
the present study, the association was inverse but not sta-
tistically significant. Another case–control study showed a
moderate inverse association between magnesium level in
drinking water and prostate cancer mortality [58]. How-
ever, the relationship for magnesium intake from food has
never been reported. As the result of the present study
suggests, dietary magnesium intake might have no asso-
ciation with prostate cancer risk, whether for overall
prostate cancer or for advanced and non-advanced types
separately. The null association of dietary magnesium
intake with overall cancer mortality in the present study is
in agreement with the result of the Swedish male cohort
[34]. Based on these limited data, it seems that dietary
magnesium intake might have no effect on cancer inci-
dence and mortality. However, a solid conclusion could not
be drawn until more evidence becomes available.
Several limitations of the present study should be noted.
Firstly, a FFQ, even though it has been validated before
application, is a relatively rough instrument to quantify
nutrient intakes and thus results are affected by measure-
ment error. Secondly, as shown in the present study,
participants with higher dietary calcium intake were more
likely to take calcium/vitamin D supplements. However,
calcium intake from supplements was not quantified.
Lastly, some important cancer risk factors, such as family
history and cancer screening, were not adjusted for in the
present study, and therefore, residual confounding may
exist. However, we additionally adjusted for dietary vita-
min K2 intake, an important confounder that had not been
controlled for in any of the previous studies.
In summary, this German prospective cohort study
provides no strong evidence to support that high dietary
calcium and magnesium intake in the intake range
observed in a German population may reduce the risk of
cancer incidence, in total or for common site-specific types,
and overall cancer mortality.
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